Global Anticoagulants Market: Size, Trends & Forecasts 2017-2021

"The Report Global Anticoagulants Market: Size, Trends & Forecasts (2017-2021) provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

Description
Scope of the Report
The report entitled Global Anticoagulants Market: Size, Trends & Forecasts (2017-2021) provides an in-depth analysis of the global anticoagulants market with description of market size and growth. The analysis include market share by treatment, by segment, and by products.
Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1068332
The report also provides analysis of injectable and oral anticoagulants available in the market. Details of Lovenox, Arixtra, Xarelto, Eliquis, Pradaxa and Savaysa has been provided in the report in terms of their global sales.
A brief analysis of the US anticoagulants market has also been provided in terms of value and sales of top four oral anticoagulant drugs in the region.
Furthermore, the report also assesses the key opportunities available in the market and outline the market dynamics that are and will be accountable for growth of the industry. Growth of the global anticoagulants market has also been forecasted for the period 2017-2021, taking into consideration previous growth outlines, growth drivers and the existing and forthcoming trends.
Bayer, BMS/Pfizer, Boehringher Ingelheim and Daiichi Sankyo are some of the key players operating in the global anticoagulants market, whose company profiling has been done in the report. This segment summarizes business overview, financial overview and the business strategies of the companies.
Company Coverage
Bayer Group
BMS/Pfizer
Boehringher Ingelheim
Daiichi Sankyo
Country Coverage
The US
View Report @ https://www.marketresearchreports.biz/reports/1068332/global-anticoagulants-size-trends-forecasts-market-research-reports
Executive Summary
Anticoagulants which are also known as blood thinners are drugs that are prescribed to prevent blood from clotting or stop existing clots from getting larger. The drugs prevent harmful clots forming in heart, veins or arteries. Formation of clots in the blood can lead to heart attack or stroke. These drugs are used to treat strokes, myocardial infarctions, pulmonary embolisms, disseminated intravascular coagulation (DIC) and deep vein thrombosis (DVT)- all potentially life-threatening conditions. Anticoagulants work by interrupting the process involved in the formation of blood clots.
The most commonly prescribed anticoagulant is Warfarin. Newer types of anticoagulants are also available and are becoming increasingly common. These include rivaroxaban (Xarelto), dabigatran (Pradaxa), apixaban (Eliquis), and edoxaban (Savaysa/Lixiana). Warfarin and the newer alternatives are taken as tablets or capsules. There's also an anticoagulant called heparin that can be given by injection.
The global anticoagulants market has increased over the years and is expected to grow in the next four years i.e. 2017-2021, particularly due to development of novel oral anticoagulants (NOACs). The global anticoagulants market is supported by various growth drivers such as growing aging population, rising prevalence of coagulant disorders, increasing demand for NOACs, rising awareness about anticoagulants, etc. Yet, the market faces some challenges which are obstructing the growth of the market. Some of the challenges are stringent regulations from regulatory bodies, high cost of oral anticoagulants, major side-effects associated with the drugs, etc.
Table of Content
1. Executive Summary
2. Introduction
2.1 Overview of Anticoagulants
2.1.1 Types of Anticoagulants
2.1.2 Novel Oral Anticoagulants
Browse more Pharmaceutical Market Research Reports @ https://www.marketresearchreports.biz/category/38
3. Global Market Analysis
3.1 Global Anticoagulants Market Analysis
3.1.1 Global Anticoagulants Market by Value
3.1.2 Global Anticoagulants Market Share by Treatment
3.1.3 Global Anticoagulants Market Share by Segment
3.1.4 Global Anticoagulants Market Share by Products
4. Global Anticoagulants Product Analysis
4.1 Injectable Anticoagulants Product Analysis
4.1.1 Global Lovenox Market by Value
4.1.2 Global Arixtra Market by Value
4.2 Oral Anticoagulants Product Analysis
4.2.1 Global Xarelto Market by Value 27
4.2.2 Global Eliquis Market by Value 28
4.2.3 Global Pradaxa Market by Value 29
4.2.4 Global Savaysa Market by Value 30
Request for Enquiry @ https://www.marketresearchreports.biz/sample/enquiry/1068332
5. Region/Country Analysis
5.1 The US Anticoagulants Market Analysis
5.1.1 The US Anticoagulants Market by Value
5.1.2 The US Xarelto Market by Value
5.1.3 The US Eliquis Market by Value
5.1.4 The US Pradaxa Market by Value
5.1.5 The US Savaysa Market by Value
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Growing Aging Population
6.1.2 Rising Prevalence of Coagulation Disorder
6.1.3 Increasing Demand for NOACs
6.1.4 Rising Awareness about Anticoagulants
6.1.5 Pressure to Curtail Spending on Healthcare
6.1.6 Increasing Incidence of Atrial Fibrillation
6.2 Challenges
6.2.1 High Cost Of NOACs
6.2.2 Lack of Antidotes for NOACs
6.2.3 Strict Regulations
6.2.4 Side Effects Associated with Drugs
6.3 Market Trends
6.3.1 Strategic Alliance
6.3.2 Expanding Therapeutic Applications
6.3.3 Patient Assistance Programs

About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact us

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz

This release was published on openPR.